IUHSA
IONS icon

Itau Unibanco Holding S.A.’s Ionis Pharmaceuticals IONS Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,121
Closed -$73.3K – 415
2025
Q3 		$73.3K Sell
1,121
-3
-0.3% -$146 ﹤0.01% 212
2025
Q2 		$44.4K Sell
1,124
-19
-2% -$622 ﹤0.01% 267
2025
Q1 		$34K Sell
1,143
-8
-0.7% -$262 ﹤0.01% 318
2024
Q4 		$40.2K Buy
1,151
+70
+6% +$2.62K ﹤0.01% 294
2024
Q3 		$43.3K Buy
1,081
+314
+41% +$14.6K ﹤0.01% 199
2024
Q2 		$36.6K Buy
+767
New +$31.5K ﹤0.01% 188
2024
Q1 		– Sell
-1,429
Closed -$72.3K – 243
2023
Q4 		$72.3K Sell
1,429
-378
-21% -$18.1K ﹤0.01% 194
2023
Q3 		$82K Sell
1,807
-8
-0.4% -$330 ﹤0.01% 219
2023
Q2 		$74.5K Sell
1,815
-27
-1% -$1.04K ﹤0.01% 264
2023
Q1 		$65.8K Sell
1,842
-6
-0.3% -$225 ﹤0.01% 314
2022
Q4 		$69.8K Buy
1,848
+10
+0.5% +$421 ﹤0.01% 319
2022
Q3 		$81K Sell
1,838
-813
-31% -$34.3K ﹤0.01% 346
2022
Q2 		$98K Sell
2,651
-140
-5% -$5.28K ﹤0.01% 287
2022
Q1 		$103K Sell
2,791
-13
-0.5% -$426 ﹤0.01% 268
2021
Q4 		$86K Buy
2,804
+1,563
+126% +$49.2K ﹤0.01% 232
2021
Q3 		$42K Buy
1,241
+373
+43% +$14.1K ﹤0.01% 283
2021
Q2 		$35K Buy
+868
New +$34K ﹤0.01% 246

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Itau Unibanco Holding S.A.'s IONS Position: Q4 2025 in Review

Itau Unibanco Holding S.A. sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 1,121 shares — an estimated $73.3K sold.

Itau Unibanco Holding S.A. first reported a position in IONS in Q2 2021 and held it in 17 quarters. The position peaked at $103K in Q1 2022. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Itau Unibanco Holding S.A. reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,121 Ionis Pharmaceuticals shares in Q4 2025, an estimated $73.3K.
  • Itau Unibanco Holding S.A. first reported a position in Ionis Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Itau Unibanco Holding S.A.'s Ionis Pharmaceuticals position peaked at $103K in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2025, filed 13 Feb 2026.